Research never stops

Financial Key Figures According to IFRS



2016 2015 16|15 in %

Results:




Revenues T€ 164,507 127,677 29
R&D expenses T€ (18,108) (18,343) (1)
Operating result T€ 31,342
11,640 169
Adjusted Group EBITDA* T€ 36,225 8,690 317
Net income T€ 26,839 16,516 63

Balance sheet data:




Total stockholders' equity T€ 213,936 187,094 14
Capital expenditure** T€ 10,149 11,496 (12)
Cash, cash equivalents and investments

 

T€

 

126,270

 

133,940

 

(6)

Balance sheet total T€ 351,366 288,538 22
Operating cash flow T€ 67,360 15,651 330





Personnel data:




Employees as of 31 Dec 1,238 1,000 24

Per share:




Result (basic/diluted)
Euro 0.20/0.20 0.13/0.12

* EBITDA was adjusted for changes in contingent consideration as well as for the bargain purchase resulting from the acquisition of Evotec (France) SAS in 2015.
** Cash relevant purchase of tangible and intangible assets